Age-Dependent Consequences of Status Epilepticus: Animal Models

Epilepsia ◽  
2007 ◽  
Vol 48 (s2) ◽  
pp. 75-82 ◽  
Author(s):  
Morris H. Scantlebury ◽  
James G. Heida ◽  
Henry J. Hasson ◽  
Jana Velíšková ◽  
Libor Velíšek ◽  
...  
2019 ◽  
pp. 106831 ◽  
Author(s):  
Cristiane Queixa Tilelli ◽  
Larissa Ribeiro Flôres ◽  
Vinicius Rosa Cota ◽  
Olagide Wagner de Castro ◽  
Norberto Garcia-Cairasco

2012 ◽  
Vol 100 (1-2) ◽  
pp. 80-92 ◽  
Author(s):  
Tiina-Kaisa Kukko-Lukjanov ◽  
Maria Grönman ◽  
Minnamaija Lintunen ◽  
Hanna B. Laurén ◽  
Kimmo A. Michelsen ◽  
...  

2018 ◽  
Vol 29 (7) ◽  
pp. 757-770 ◽  
Author(s):  
Nikita Nirwan ◽  
Preeti Vyas ◽  
Divya Vohora

Abstract Temporal lobe epilepsy (TLE) is the chronic and pharmacoresistant form of epilepsy observed in humans. The current literature is insufficient in explicating the comprehensive mechanisms underlying its pathogenesis and advancement. Consequently, the development of a suitable animal model mimicking the clinical characteristics is required. Further, the relevance of status epilepticus (SE) to animal models is dubious. SE occurs rarely in people; most epilepsy patients never experience it. The present review summarizes the established animal models of SE and TLE, along with a brief discussion of the animal models that have the distinctiveness and carries the possibility to be developed as effective models for TLE. The review not only covers the basic requirements, mechanisms, and methods of induction of each model but also focuses upon their major limitations and possible modifications for their future use. A detailed discussion on chemical, electrical, and hypoxic/ischemic models as well as a brief explanation on the genetic models, most of which are characterized by development of SE followed by neurodegeneration, is presented.


1998 ◽  
Vol 18 (23) ◽  
pp. 10070-10077 ◽  
Author(s):  
Andrey M. Mazarati ◽  
Hantao Liu ◽  
Ursel Soomets ◽  
Raman Sankar ◽  
Don Shin ◽  
...  

2020 ◽  
Vol 21 (12) ◽  
pp. 4250
Author(s):  
Yuzuru Imai

Parkinson’s disease (PD) is the second most common neurodegenerative disorder characterized by age-dependent motor dysfunction and degeneration of the midbrain dopaminergic neurons [...]


2017 ◽  
pp. 3-17
Author(s):  
Inna Keselman ◽  
Claude G. Wasterlain ◽  
Jerome Niquet ◽  
James W. Y. Chen

PLoS ONE ◽  
2015 ◽  
Vol 10 (3) ◽  
pp. e0119411
Author(s):  
Sungkwon Chung ◽  
Nelson Spruston ◽  
Sookyong Koh

Epilepsia ◽  
2008 ◽  
Vol 49 (5) ◽  
pp. 832-841 ◽  
Author(s):  
Juha T. Järvelä ◽  
Francisco R. Lopez-Picon ◽  
Irma E. Holopainen

Sign in / Sign up

Export Citation Format

Share Document